At picomolar doses, both ADCs killed GPC3-positive cancer cell lines (Hep3B, HepG2, and Huh 7); however, the PBD dimer-based ADC was 5-10 times more effective than the duocarmycin SA-based one [2]. Here, GPC3 is linked to cancer.